MicroRNA-16 sensitizes drug-resistant breast cancer cells to Adriamycin by targeting Wip1 and Bcl-2

Clinical evidence indicates that drug resistance is a major obstacle in the treatment of breast cancer (BC). Drug resistance results in the disease being uncontrollable, and leads to high mortality rates. The aim of the present study was to investigate the chemosensitizing effect of microRNA (miR)-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xitao, Wang, Mei, Zhang, Yanyan, Xu, Zhi, Ding, Jiaji, Tang, Jinhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676408/
https://www.ncbi.nlm.nih.gov/pubmed/31452770
http://dx.doi.org/10.3892/ol.2019.10637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676408/
https://www.ncbi.nlm.nih.gov/pubmed/31452770
http://dx.doi.org/10.3892/ol.2019.10637

Ejemplares similares